Waters CORP /DE/ 10-Q quarterly reports

Waters Corporation's Q2 2026 10-Q filing reveals a significant net loss and increased debt, largely due to the recent BDS Business Acquisition, despite substantial revenue growth.

Waters Corporation reported a net loss for the first quarter of 2026, significantly impacted by the recent acquisition of Becton, Dickinson and Company's Biosciences & Diagnostic Solutions business.

Waters Corporation reported an 8% increase in Q3 net sales to $799.9 million, driven by strong demand for Waters Division products, though operating income declined due to significant merger-related and ERP implementation costs.

Waters Corporation reported a 9% increase in Q2 2025 net sales and a 3% rise in net income, while announcing a transformative $17.5 billion merger with BD's Biosciences & Diagnostic Solutions business.

Waters Corporation's Q1 2025 sales increased by 4%, driven by strong demand for LC, MS, and LC & MS instrument systems.

Waters Corporation's Q3 2024 results show a 4% increase in net sales, driven by strong customer demand, but year-to-date sales are down 2% due to delayed capital spending.

Waters Corporation's second-quarter results show a decrease in sales and operating income, impacted by lower customer demand and acquisition-related expenses, despite growth in recurring revenues.

Waters Corporation experienced a 7% decrease in net sales and a 27% drop in net income for the first quarter of 2024, primarily due to lower customer demand for its products.